EVENITY(TM) (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture

EVENITY Approved to Reduce the Risk of Fractures and Increase Bone Mineral Density in Men and Postmenopausal Women With Osteoporosis at High Risk of Fracture EVENITY in Japan is Being Co-Developed Through a Strategic Alliance With Amgen Astellas BioPhar... Biopharmaceuticals, Regulatory Amgen, UCB, Astellas, EVENITY, romosozumab, osteoporosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news